|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.003 AUD | -25.00% |
|
-33.33% | -92.50% |
| Apr. 16 | Melodiol Global's Revenue Surges 79% in Q1 | MT |
| Apr. 09 | Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic | MT |
Melodiol Global Health Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was AUD 18.92 million compared to AUD 6.24 million a year ago. Net loss was AUD 52.45 million compared to AUD 32.78 million a year ago.
Basic loss per share was AUD 0.376 compared to AUD 0.448 a year ago. Diluted loss per share was AUD 0.376 compared to AUD 0.448 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -92.50% | 1.32M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
MELODIOL GLOBAL HEALTH LIMITED 
